While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

LoL's ARAM Mayhem mode is getting some significant updates in the 26.03 PBE, with new progession meta progress, new augments, and sets too.

Tech billionaires are racing to reach artificial general intelligence—even if it makes us obsolete ...

AI models can process thousands of factors simultaneously, including demand signals across multiple items, macroeconomic ...

Explore Dogecoin price prediction 2026 & XRP current price action shape the market while ZKP emerges as the next crypto to ...

The evidence shows that, under controlled conditions, LLM judges can align closely with clinician judgments on concrete, ...

Welcome to the era of "Action Drift," where your agents are negotiating trades your CRO won’t understand for another six ...

Generative AI was trained on centuries of art and writing produced by humans. But scientists and critics have wondered what would happen once AI became widely adopted and started training on its ...

Hi! If you’re finding value in our Applied AI newsletter, I encourage you to consider subscribing to The Information. It contains exclusive reporting on the most important stories in tech, like this ...

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the market? This article walks through what the current numbers may be telling ...